Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards of each drug product to determine the need for changes in specifications or manufacturing or control procedures.
Inspection Record
The Mentholatum Company — FDA 483 Findings
Inspectors Lauren H AugustyniakThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory records do not include the quantity of the sample.
Determinations of conformance to appropriate written specifications for acceptance are deficient for drug products.
There is a failure to thoroughly review the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Fenwal International, Inc.2024-09-18 · US FDASimilar to finding 1 Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards of each drug product to determine the need…
- McNeil Consumer Healthcare Inc.2015-07-10 · US FDASimilar to finding 1 Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards of each drug product to determine the need…
- Glenmark Pharmaceuticals Ltd.2017-11-11 · US FDASimilar to finding 1 Records are not maintained so that data therein can be reviewed at least annually to evaluate the quality standards ofeach drug product to determine the need…
- Jiangsu Hansoh Pharmaceutical Group Co Ltd.2026-04-24 · US FDASimilar to finding 4 Your firm failed to thoroughly investigate any unexplained discrepancy or failure ofa batch or any of its components to meet any of its specifications whether…
- Biomylz Private Limited2026-02-09 · US FDASimilar to finding 4 Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications…
A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.